Literature DB >> 11940211

Epithelioid trophoblastic tumor of the uterus: cytological and immunohistochemical observation of a case.

Seiryu Kamoi1, Yoshiharu Ohaki, Osamu Mori, Munehiro Yokoyama, Youko Kawamoto, Takashi Kawamura, Tsutomu Araki.   

Abstract

Epithelioid trophoblastic tumor (ETT) is a new entity of trophoblastic tumor and 14 such cases were reported by Shih and Kurman in 1998. However, only three subsequent cases supporting ETT have been reported. Recently, we experienced a case of ETT in a 37-year-old woman whose preoperative endometrial brushings showed atypical mononucleate giant cells and who underwent hysterectomy with the diagnosis of a uterine fibroid. The specimens revealed a 2.5 x 3.0 cm yellow-tan intramural nodule located in the lower uterine segment, which was composed of a neoplastic proliferation of intermediate trophoblasts in epithelioid arrangements. Immunohistochemically, the tumor cells were diffusely positive for cytokeratin and inhibin-alpha, and focally positive for human chorionic gonadotropin and human placental lactogen. She presented an uneventful clinical course as of September 2001.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11940211     DOI: 10.1046/j.1440-1827.2002.01313.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  2 in total

1.  P57kip2 immunohistochemical expression and ultrastructural findings of gestational trophoblastic disease and related disorders.

Authors:  Hiroaki Soma; Hiroyuki Osawa; Tatsuo Oguro; Isao Yoshihama; Koji Fujita; Shoichiro Mineo; Motoshige Kudo; Kayoko Tanaka; Masumi Akita; Satoshi Urabe; Yoshiki Kudo
Journal:  Med Mol Morphol       Date:  2007-06-18       Impact factor: 2.309

2.  Sonographic image of cervix epithelioid trophoblastic tumor coexisting with mucinous adenocarcinoma in a postmenopausal woman: A case report.

Authors:  Yi Zhu; Guo-Nan Zhang; Rui-Bo Zhang; Yu Shi; Deng-Feng Wang; Rong He
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.